Globalization tangles early access programs into legal maze
Experts have urged that legislation on early access programs needs to be tightened to protect the seriously ill Through expanded early access programs (EAPs), terminally- ill patients that fit certain criteria will be allowed access to unauthorized drugs outside of a clinical trial.These programs aim to give dying patients ethical and controlled strategic access to potentially life- saving medicines before they gain approval. However, the lack of clarity and harmonization of regional regul...
To continue reading this story get free access
Please note: That all fields marked with an asterisk (*) are required.